FS Bancorp, Inc. current report, 07 September 2017

FS Bancorp, Inc. Form 8-K Summary

Business Context and Reporting Period

FS Bancorp, Inc., an emerging growth company incorporated in Washington, filed this Current Report on Form 8-K on September 7, 2017. The filing reports the entry into a definitive material agreement regarding a public equity offering.

Key Financial Metrics and Transaction Details

  • Offering Size: 510,638 shares of common stock.
  • Public Offering Price: $47.00 per share.
  • Net Proceeds per Share: $44.18 (net of underwriting discounts).
  • Estimated Net Proceeds: Approximately $22.3 million (excluding over-allotment and offering expenses).
  • Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 76,596 additional shares.
  • Expected Closing Date: On or about September 12, 2017.

The filing text does not provide current revenue, profit, cash flow, margin, debt, or liquidity metrics for the company, as this report focuses solely on the capital raise transaction.

Material Changes and Agreements

On September 7, 2017, the Company entered into an Underwriting Agreement with Raymond James & Associates, Inc. as the representative of the underwriters. This agreement facilitates a firm commitment offering. Additionally, directors and executive officers have agreed to a 90-day "lock-up" period restricting the sale of specified securities, subject to certain exceptions.

Guidance, Risks, and Contingencies

The offering is registered under a shelf registration statement on Form S-3 declared effective on February 10, 2017. The Company has agreed to indemnify the underwriters against certain liabilities arising under the Securities Act of 1933. No specific forward-looking guidance, risk factors, or unusual items beyond the standard terms of the underwriting agreement are detailed in this specific filing text.

Key Facts for Investor Verification

  • Verify the final closing date and actual net proceeds received after all offering expenses.
  • Confirm whether the underwriters exercise the 30-day over-allotment option for an additional 76,596 shares.
  • Review the final prospectus supplement dated September 7, 2017, for detailed use of proceeds.
  • Monitor compliance with the 90-day lock-up period for directors and executive officers.